scholarly journals A novel MYH9 mutation in a beta thalassemia major patient with thrombocytopenia

2018 ◽  
Vol 19 (3) ◽  
pp. 271-272
Author(s):  
Didem Torun Özkan ◽  
Nejat Akar
Keyword(s):  
Thalassemia Major ◽  
Beta Thalassemia ◽  
Beta Thalassemia Major ◽  
Thalassemia Major Patient ◽  
Myh9 Mutation

Beta Thalassemia Major with Diabetes Mellitus: A Case Report

2021 ◽  
Vol 8 (2) ◽  
pp. 85-88
Author(s):  
Dr. Sneha Mhaske ◽  
Dr. Abhijit Shinde ◽  
Dr. Sonal Shinde ◽  
Dr. Ramesh Kothari ◽  
Dr. Ganesh Misal ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Blood Sugar Level ◽  
Chelating Agent ◽  
Thalassemia Major ◽  
Beta Thalassemia ◽  
Laboratory Examination ◽  
Beta Thalassemia Major ◽  
Thalassemia Major Patient ◽  
Urine Sugar ◽  
Hemoglobin Production

Thalassemia results from defects in normal hemoglobin production, and represents the most common inherited anemia worldwide. Diabetes is a complication of b-thalassemia major. We report a case of Diabetes mellitus in a known case of beta thalassemia major. Patient had undergone Splenectomy 1 year back. Patient is taking chelating agent Defasirox 1000mg orally once a day in the morning. Family history reveals, born through third degree consanguineous marri age. The patient was then subjected for laboratory examination reveals BSL was high, urine ketone 2+,urine sugar 3+, ABG was normal, HbA1c was 13 & 3 month old report of  serum ferritin 1200 ng/dl. Multidisciplinary management was instituted. Blood sugar level got controlled over subcutaneous insulin. Patient may have landed in Diabetic ketoacidosis but was promptly diagnosed & treated. This case is presented for its rarity. As the life expectancy of patients with thalassaemia increases, this will also expose our patients potentially to many more years of hyperglycaemia and diabetes. Sustaining metabolic control and controlling cardiovascular risk factors will be critical in the future for preventing complications due to diabetes.

scholarly journals Comprehensive management of refractory autoimmune hemolytic anemia in pediatric beta-thalassemia major patient: A case report

2021 ◽  
pp. 102853
Author(s):  
Vincencius William ◽  
Desy Rusmawatiningtyas ◽  
Firdian Makrufardi ◽  
Pudjo Hagung Widjajanto
Keyword(s):  
Case Report ◽  
Hemolytic Anemia ◽  
Autoimmune Hemolytic Anemia ◽  
Thalassemia Major ◽  
Beta Thalassemia ◽  
Comprehensive Management ◽  
Beta Thalassemia Major ◽  
Thalassemia Major Patient

scholarly journals COVID-19 reinfection in Beta-Thalassemia Major Patient: first case report.

2020 ◽  
Author(s):  
Lina Okar ◽  
Rita Ahmad ◽  
mohamed yassin
Keyword(s):  
Case Report ◽  
Thalassemia Major ◽  
Beta Thalassemia ◽  
Beta Thalassemia Major ◽  
First Case ◽  
Thalassemia Major Patient

Paradoxically Increased Ferritin Level in a Beta-Thalassemia Major Patient following the Start of Deferasirox Chelation Therapy

2010 ◽  
Vol 123 (2) ◽  
pp. 117-120
Author(s):  
Paolo Ricchi ◽  
Massimiliano Ammirabile ◽  
Anna Spasiano ◽  
Silvia Costantini ◽  
Patrizia Cinque ◽  
...  
Keyword(s):  
Chelation Therapy ◽  
Ferritin Level ◽  
Thalassemia Major ◽  
Beta Thalassemia ◽  
Beta Thalassemia Major ◽  
Thalassemia Major Patient

scholarly journals Transplant- Associated Thrombotic Microangiopathy in a Beta-Thalassemia Major Patient Following Bone Marrow Transplant- Case Report

2014 ◽  
Vol 20 (2) ◽  
pp. S189
Author(s):  
Ghada Abusin ◽  
Ugochi Ogu ◽  
Ayman Aly El-Sheikh ◽  
Steve Rumelhart ◽  
Diana Zepeda-Orozco ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Case Report ◽  
Bone Marrow Transplant ◽  
Thrombotic Microangiopathy ◽  
Thalassemia Major ◽  
Marrow Transplant ◽  
Beta Thalassemia ◽  
Beta Thalassemia Major ◽  
Thalassemia Major Patient
Sign in / Sign up

Export Citation Format

Share Document